Sign Out
Carvedilol is contraindicated in patients with NYHA class IV decompensated cardiac failure requiring intravenous inotropic therapy, bronchial asthma or related bronchospastic conditions, second or third degree AV block, sick sinus syndrome (unless a permanent pacemaker is in place), cardiogenic shock or severe bradycardia.
Use of Carvedilol in patients with clinically manifested hepatic impairment is not recommended.
Carvedilol is contraindicated in patients with hypersensitivity to the drug.
Continue with Google